市場調查報告書

過敏性鼻炎的全球市場:至2025年的預測

Global Allergic Rhinitis Market Research Report - Forecast till 2025

出版商 Market Research Future 商品編碼 922981
出版日期 內容資訊 英文 129 Pages
訂單完成後即時交付
價格
過敏性鼻炎的全球市場:至2025年的預測 Global Allergic Rhinitis Market Research Report - Forecast till 2025
出版日期: 2019年12月01日內容資訊: 英文 129 Pages
簡介

全球過敏性鼻炎市場至2025年預計將以3.1%的年複合成長率發展,成長到150億6,412萬美元的規模。由於過敏性鼻炎的發生率的上升,及政府對過敏性疾病的啟發活動的配合措施等促進該市場成長。各治療類型中,抗組織胺藥佔40.4%的佔有率。

本報告提供全球過敏性鼻炎市場調查,市場概要,各種類、治療類型、給藥途徑、流通管道、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

目錄

第1章 摘要整理

  • 市場概要
  • 主要的貢獻要素

第2章 市場介紹

  • 定義
  • 調查範圍
  • 調查目的
  • 市場結構
  • 假設與限制

第3章 調查方法

  • 資料探勘
  • 二次研究
  • 一次研究
  • 預測技術
  • 市場規模估計的調查方法

第4章 市場動態

  • 簡介
  • 成長要素
    • 過敏性鼻炎的增加
    • 政府的啟發活動的增加
    • 醫療費的增加
  • 阻礙因素
    • 專利失效
    • 過敏性鼻炎的治療藥的副作用
  • 市場機會
    • 發展中國家的需求的增加
    • 更高度的產品

第5章 市場要素分析

  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入廠商的威脅
    • 替代威脅
    • 對手的實力
  • 價值鏈分析
    • 研究開發
    • 製造業
    • 經銷與銷售
    • 銷售後的監視

第6章 全球過敏性鼻炎市場:各類型

  • 概要
  • 季節性過敏性鼻炎
  • 全身性過敏性鼻炎
  • 職業性過敏性鼻炎

第7章 全球過敏性鼻炎市場:各治療類型

  • 簡介
  • 抗組織胺藥物
  • 皮質類固醇
  • 充血消除劑
  • 免疫療法
  • 鼻腔內抗膽鹼藥
  • 其他

第8章 全球過敏性鼻炎市場:各給藥途徑

  • 概要
  • 經鼻子給藥
  • 口服給藥
  • 其他

第9章 全球過敏性鼻炎市場:各流通管道

  • 概要
  • 零售藥局
  • 醫院藥局
  • 網路商店

第10章 全球過敏性鼻炎市場:各地區

  • 簡介
  • 南北美洲
    • 北美
    • 中南美
  • 歐洲
  • 亞太地區
  • 中東、非洲

第11章 競爭情形

  • 簡介

第12章 企業簡介

  • ASTRAZENECA
  • BOEHRINGER INGELHEIM
  • MERCK & CO., INC.
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON SERVICES, INC.
  • BAYER AG
  • ALK-ABELLO A/S
  • MEDA PHARMACEUTICALS
  • SANOFI
  • NOVARTIS AG

第13章 附錄

  • 參考文獻
  • 相關報告
目錄

Global Allergic Rhinitis Market: Information by Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), Treatment (Antihistamines, Corticosteroids, Immunotherapy, Decongestants and others), Route of Administration (Oral, Nasal and others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Stores) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Market Analysis:

Allergic Rhinitis Market is expected to register a CAGR of 3.10% to reach USD 15064.12 Million by the year 2025. The Global Allergic Rhinitis Market is projected to expose profitable growth during the forecast period. Some of the significant factors characterizing the market growth are the increasing incidence of allergic rhinitis and increasing government initiatives to spread awareness about allergic diseases. However, the side-effects related usage of Allergic Rhinitis is anticipated to limit market growth over the forecast period. Allergic rhinitis, also known as hay fever, is an allergic disease associated with the nose. The allergic rhinitis affects when the immune system of the human body becomes clarified and overreacts to specific allergens in the environment, which are generally not harmful to most of the people. Allergic rhinitis may be classified as three different types viz., seasonal, perennial, and occupational. The increasing prevalence of allergic rhinitis, increasing government initiatives to promote awareness regarding allergic rhinitis, and growing healthcare expenditure and expansion of the private healthcare system is likely to drive the growth of the global allergic rhinitis market during the forecast period. For instance, according to the European Academy of Allergy and Clinical Immunology (EAACI), stated that over 150 million Europeans suffer from chronic allergic disease, out of which 100 million Europeans suffer from allergic rhinitis.

Market Segmentation:

By type the Global Allergic Rhinitis Market has been segmented into Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis and Occupational Allergic Rhinitis. The antihistamines segment held a share of 40.4% in 2018. By Treatment the Global Allergic Rhinitis Market has been divided into Antihistamines, orticosteroids, Decongestants, Immunotherapy, Intranasal Anticholinergicsa and Others. By Route of Administration the global allergic rhinitis market has been segmented into Nasal, Oral and Others. Based on distribution channel the Global Allergic Rhinitis Market has been segmented into Retail Pharmacies, Hospital Pharmacies and Online Stores. Global Allergic Rhinitis Market into different regions like Americas broken into North America & Latin America. North America is sub-divided into US & Canada. Europe is split into the Western Europe and Eastern Europe. Western Europe is sub-divided into Germany, UK, France, Italy, Spain and Rest of Western Europe. Asia-Pacific including Japan, China, India, Australia, South Korea and Rest of Asia-Pacific, Middle East & Africa.

Regional Analysis:

Geographically, the global allergic rhinitis market has been segmented into regions like Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas dominates the global allergic rhinitis market owing to the presence of major market players in the region, strategic acquisitions by major players to augment product portfolio, growing cases of respiratory disorders, and availability of advanced medications for the treatment of allergic rhinitis. For the instance, the National Centre for Biotechnology Information (NCBI) stated that the prevalence of allergic rhinitis in the US is approximately 15%, which are physician-diagnosed. The European region holds the second-largest market share owing to the adoption of advanced processing by hospitals and patients in the European countries, and ongoing efforts made by Global Allergy and Asthma European Network to strengthen European research, spread excellence. Asia-Pacific are estimated to be the fastest-growing region in the global market due to the continuous developments in developing countries like India and China. Emerging economies are expected to explain maximum cases of allergic rhinitis due to tobacco smoke, exposure to air pollutants in the home and workplace, vehicular pollution, and indoor air pollution, this is likely to drive the growth of the market. This region is expected to grow at a CAGR of 3.65% during the forecast period of 2019 to 2025. The allergic rhinitis market in the Middle East & Africa is expected to witness a modest market growth rate from the year 2019 to 2025. The established countries in the Middle East, such as the UAE and Saudi Arabia are the ones with the maximum share in the allergic rhinitis market. The advanced healthcare infrastructure boosted healthcare expenditure and growing per capita disposable incomes of the people in these countries are some factors contributing to their large share of the market in this region.

Major Players:

AstraZeneca, GlaxoSmithKline plc, Johnson & Johnson Services, Inc, Bayer AG, Sanofi, Boehringer Ingelheim, Merck & Co., ALK-Abello A/S, Novartis AG, Meda Pharmaceuticals, and others are some of the prominent players in the Global Allergic Rhinitis Market. Some of the projected onlookers for the Global Allergic Rhinitis Market are Allergic rhinitis drugs manufacturing companies, Research & development organizations and Academic institutes.

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 MARKET SYNOPSIS
  • 1.2 KEY CONTRIBUTING FACTORS

2 Market Introduction

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
    • 3.3.1 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.4 FORECASTING TECHNIQUES
  • 3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.5.1 BOTTOM-UP APPROACH
    • 3.5.2 TOP-DOWN APPROACH
    • 3.5.3 DATA TRIANGULATION
    • 3.5.4 VALIDATION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 RISING PREVALENCE OF ALLERGIC RHINITIS
    • 4.2.2 GOVERNMENT INITIATIVES TO CREATE AWARENESS
    • 4.2.3 INCREASING HEALTHCARE EXPENDITURE
  • 4.3 RESTRAINTS
    • 4.3.1 PATENT EXPIRY
    • 4.3.2 SIDE EFFECTS OF TREATMENT FOR ALLERGIC RHINITIS
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING DEMAND IN DEVELOPING COUNTRIES
    • 4.4.2 MORE ADVANCED PRODUCTS

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 VALUE CHAIN ANALYSIS
    • 5.2.1 R&D
    • 5.2.2 MANUFACTURING
    • 5.2.3 DISTRIBUTION & SALES
    • 5.2.4 POST-SALES MONITORING

6 GLOBAL ALLERGIC RHINITIS MARKET BY TYPE

  • 6.1 OVERVIEW
  • 6.2 SEASONAL ALLERGIC RHINITIS
  • 6.3 PERENNIAL ALLERGIC RHINITIS
  • 6.4 OCCUPATIONAL ALLERGIC RHINITIS

7 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT

  • 7.1 INTRODUCTION
  • 7.2 ANTIHISTAMINES
  • 7.3 CORTICOSTEROIDS
  • 7.4 DECONGESTANTS
  • 7.5 IMMUNOTHERAPY
  • 7.6 INTRANASAL ANTICHOLINERGICS
  • 7.7 OTHERS

8 GLOBAL ALLERGIC RHINITIS MARKET BY ROUTE OF ADMINISTRATION

  • 8.1 OVERVIEW
  • 8.2 NASAL
  • 8.3 ORAL
  • 8.4 OTHERS

9 GLOBAL ALLERGIC RHINITIS MARKET BY DISTRIBUTION CHANNEL

  • 9.1 OVERVIEW
  • 9.2 RETAIL PHARMACIES
  • 9.3 HOSPITAL PHARMACIES
  • 9.4 ONLINE STORES

10 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 AMERICAS
    • 10.2.1 NORTH AMERICA
    • 10.2.2 LATIN AMERICA
  • 10.3 EUROPE
  • 10.4 ASIA-PACIFIC
  • 10.5 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION

12 COMPANY PROFILES

  • 12.1 ASTRAZENECA
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS/SERVICES OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 BOEHRINGER INGELHEIM
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS/SERVICES OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 KEY STRATEGIES
  • 12.3 MERCK & CO., INC.
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS/SERVICES OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 SWOT ANALYSIS
    • 12.3.6 KEY STRATEGIES
  • 12.4 GLAXOSMITHKLINE PLC
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS/SERVICES OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 SWOT ANALYSIS
    • 12.4.6 KEY STRATEGIES
  • 12.5 JOHNSON & JOHNSON SERVICES, INC.
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS/SERVICES OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 SWOT ANALYSIS
    • 12.5.6 KEY STRATEGIES
  • 12.6 BAYER AG
    • 12.6.1 COMPANY OVERVIEWS
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS/SERVICES OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 SWOT ANALYSIS
    • 12.6.6 KEY STRATEGIES
  • 12.7 ALK-ABELLO A/S
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS/SERVICES OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 SWOT ANALYSIS
    • 12.7.6 KEY STRATEGIES
  • 12.8 MEDA PHARMACEUTICALS
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS/SERVICES OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 SWOT ANALYSIS
    • 12.8.6 KEY STRATEGIES
  • 12.9 SANOFI
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS/SERVICES OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 SWOT ANALYSIS
    • 12.9.6 KEY STRATEGIES
  • 12.10 NOVARTIS AG
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS/SERVICES OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 SWOT ANALYSIS
    • 12.10.6 KEY STRATEGIES

13 APPENDIX

  • 13.1 REFERENCES
  • 13.2 RELATED REPORTS

List of Tables

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 4 GLOBAL ALLERGIC RHINITIS MARKET FOR SEASONAL ALLERGIC RHINITIS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 5 GLOBAL ALLERGIC RHINITIS MARKET FOR PERENNIAL ALLERGIC RHINITIS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 6 GLOBAL ALLERGIC RHINITIS MARKET FOR OCCUPATIONAL ALLERGIC RHINITIS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 7 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 8 GLOBAL ALLERGIC RHINITIS MARKET FOR ANTIHISTAMINES, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 9 GLOBAL ALLERGIC RHINITIS MARKET FOR CORTICOSTEROIDS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 10 GLOBAL ALLERGIC RHINITIS MARKET FOR DECONGESTANTS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 11 GLOBAL ALLERGIC RHINITIS MARKET FOR IMMUNOTHERAPY, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 12 GLOBAL ALLERGIC RHINITIS MARKET FOR INTRANASAL ANTICHOLINERGICS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 13 GLOBAL ALLERGIC RHINITIS MARKET FOR OTHER TREATMENTS, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 14 GLOBAL ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 15 GLOBAL ALLERGIC RHINITIS MARKET FOR NASAL, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 16 GLOBAL ALLERGIC RHINITIS MARKET FOR ORAL, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 17 GLOBAL ALLERGIC RHINITIS MARKET FOR OTHER ROUTE OF ADMINISTRATION, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 18 GLOBAL ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 19 GLOBAL ALLERGIC RHINITIS MARKET FOR RETAIL PHARMACIES, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 20 GLOBAL ALLERGIC RHINITIS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 21 GLOBAL ALLERGIC RHINITIS MARKET FOR ONLINE STORES, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 22 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 23 AMERICAS: ALLERGIC RHINITIS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 24 AMERICAS: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 25 AMERICAS: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 26 AMERICAS: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 27 AMERICAS: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 28 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 29 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 30 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 31 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 32 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 33 US: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 34 US: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 35 US: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 36 US: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 37 CANADA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 38 CANADA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 39 CANADA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 40 CANADA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 41 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 42 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 43 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 44 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 45 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 46 BRAZIL: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 47 BRAZIL: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 48 BRAZIL: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 49 BRAZIL: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 50 ARGENTINA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 51 ARGENTINA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 52 ARGENTINA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 53 ARGENTINA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 54 COLUMBIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 55 COLUMBIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 56 COLUMBIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 57 COLUMBIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 58 CHILE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 59 CHILE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 60 CHILE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 61 CHILE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 62 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 63 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 64 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 65 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 66 EUROPE: ALLERGIC RHINITIS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 67 EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 68 EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 69 EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 70 EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 71 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 72 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 73 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 74 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 75 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 76 GERMANY: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 77 GERMANY: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 78 GERMANY: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 79 GERMANY: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 80 FRANCE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 81 FRANCE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 82 FRANCE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 83 FRANCE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 84 UK: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 85 UK: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 86 UK: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 87 UK: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 88 ITALY: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 89 ITALY: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 90 ITALY: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 91 ITALY: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 92 SPAIN: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 93 SPAIN: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 94 SPAIN: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 95 SPAIN: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 96 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 97 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 98 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 99 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 100 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 101 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 102 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 103 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 104 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 105 SIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 106 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 107 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 108 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 109 JAPAN: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 110 JAPAN: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 111 JAPAN: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 112 JAPAN: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 113 CHINA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 114 CHINA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 115 CHINA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 116 CHINA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 117 INDIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 118 INDIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 119 INDIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 120 INDIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 121 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 122 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 123 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 124 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 125 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 126 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 127 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 128 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 129 THAILAND: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 130 THAILAND: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 131 THAILAND: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 132 THAILAND: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 133 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 134 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 135 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 136 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 137 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 138 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 139 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 140 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 141 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 142 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 143 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 144 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 145 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 146 AFRICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 147 AFRICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016-2025 (USD MILLION)
  • TABLE 148 AFRICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  • TABLE 149 AFRICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  • TABLE 150 ASTRAZENECA: PRODUCTS/SERVICES OFFERED
  • TABLE 151 ASTRAZENECA: KEY DEVELOPMENTS
  • TABLE 152 BOEHRINGER INGELHEIM: PRODUCTS/SERVICES OFFERED
  • TABLE 153 BOEHRINGER INGELHEIM: KEY DEVELOPMENTS
  • TABLE 154 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 155 MERCK & CO., INC: KEY DEVELOPMENTS
  • TABLE 156 GLAXOSMITHKLINE PLC: PRODUCTS/SERVICES OFFERED
  • TABLE 157 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS
  • TABLE 158 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 159 BAYER AG: PRODUCTS/SERVICES OFFERED
  • TABLE 160 BAYER AG: KEY DEVELOPMENTS
  • TABLE 161 ALK-ABELLO A/S: PRODUCTS/SERVICES OFFERED
  • TABLE 162 ALK-ABELLO A/S: KEY DEVELOPMENTS
  • TABLE 163 MEDA PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED
  • TABLE 164 MEDA PHARMACEUTICALS: KEY DEVELOPMENTS
  • TABLE 165 SANOFI: PRODUCTS/SERVICES OFFERED
  • TABLE 166 NOVARTIS AG: PRODUCTS/SERVICES OFFERED

List of Figures

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL ALLERGIC RHINITIS MARKET: STRUCTURE
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ALLERGIC RHINITIS MARKET
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ALLERGIC RHINITIS MARKET
  • FIGURE 6 VALUE CHAIN ANALYSIS OF THE GLOBAL ALLERGIC RHINITIS MARKET
  • FIGURE 7 GLOBAL ALLERGIC RHINITIS MARKET, BY TYPE, 2018 & 2025 (USD MILLION)
  • FIGURE 8 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT, 2018 & 2025 (USD MILLION)
  • FIGURE 9 GLOBAL ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2018 & 2025 (USD MILLION)
  • FIGURE 10 GLOBAL ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2018 & 2025 (USD MILLION)
  • FIGURE 11 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, 2018 & 2025 (USD MILLION)
  • FIGURE 12 AMERICAS: ALLERGIC RHINITIS MARKET SHARE, BY REGION 2018 (%)
  • FIGURE 13 NORTH AMERICA: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY 2018 (%)
  • FIGURE 14 LATIN AMERICA: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY 2018 (%)
  • FIGURE 15 EUROPE: ALLERGIC RHINITIS MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 16 WESTERN EUROPE: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY, 2018 (%)
  • FIGURE 17 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY, 2018 (%)
  • FIGURE 18 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 19 GLOBAL ALLERGIC RHINITIS MARKET, MARKET SHARE ANALYSIS 2018 (% SHARE)
  • FIGURE 20 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 21 ASTRAZENECA: SWOT ANALYSIS
  • FIGURE 22 BOEHRINGER INGELHEIM: FINANCIAL OVERVIEW
  • FIGURE 23 BOEHRINGER INGELHEIM: SWOT ANALYSIS
  • FIGURE 24 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 MERCK & CO., INC.: SWOT ANALYSIS
  • FIGURE 26 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 GLAXOSMITHKLINE PLC.: SWOT ANALYSIS
  • FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS
  • FIGURE 30 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 BAYER AG: SWOT ANALYSIS
  • FIGURE 32 ALK-ABELLO A/S FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 33 ALK-ABELLO A/S: SWOT ANALYSIS
  • FIGURE 34 MEDA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 35 MEDA PHARMACEUTICALS: SWOT ANALYSIS
  • FIGURE 36 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 37 SANOFI: SWOT ANALYSIS
  • FIGURE 38 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 NOVARTIS AG: SWOT ANALYSIS